ARS Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Dorsey Brian | Chief Operating Officer | Sale | 21,828 | $8.71 | $190,122 | 10,789 | Nov 13, 2025 |
| Chakma Justin | Chief Business Officer | Option Exercise | 30,000 | $0.84 | $25,200 | 166,380 | Nov 12, 2025 |
| Shah Pratik | — | Gift | 250,000 | — | — | 4,574,554 | Nov 12, 2025 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $14.49 | $724,500 | 1,196,494 | Aug 21, 2025 |
| Scott Kathleen D. | Chief Financial Officer | Sale | 12,500 | $15.00 | $187,500 | 10,042 | Aug 21, 2025 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 12,344 | $14.03 | $173,186 | 1,285,103 | Aug 20, 2025 |
| Karas Eric | Chief Commercial Officer | Sale | 15,000 | $16.99 | $254,850 | 10,315 | Jul 1, 2025 |
| Flynn James E | — | Sale | 370,075 | $18.46 | $6,831,585 | 4,887,254 | Jun 27, 2025 |
| Karas Eric | Chief Commercial Officer | Option Exercise | 15,000 | $1.50 | $22,500 | 22,696 | Jun 18, 2025 |
| Fitzpatrick Alexander A | Chief Legal Officer | Sale | 102,969 | $14.10 | $1,451,863 | 89,613 | May 20, 2025 |
| SAUNDERS BRENT L | — | Sale | 120,000 | $14.25 | $1,710,000 | — | May 20, 2025 |
| Scott Kathleen D. | Chief Financial Officer | Sale | 50,000 | $14.10 | $705,000 | 7,424 | May 20, 2025 |
| Shawver Laura | — | Sale | 50,002 | $12.30 | $615,025 | 210,346 | Apr 7, 2025 |
| Karas Eric | Chief Commercial Officer | Sale | 10,000 | $14.00 | $140,000 | 7,696 | Mar 20, 2025 |
| Shawver Laura | — | Sale | 400 | $11.00 | $4,400 | 210,346 | Mar 5, 2025 |
| Shawver Laura | — | Option Exercise | 9,064 | $3.15 | $28,552 | 219,410 | Feb 3, 2025 |
| Shawver Laura | — | Sale | 50,000 | $11.10 | $555,000 | 210,346 | Jan 6, 2025 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $11.67 | $583,500 | 1,098,499 | Dec 17, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $11.67 | $583,500 | 1,297,447 | Dec 17, 2024 |
| Chakma Justin | Chief Business Officer | Sale | 117,333 | $12.27 | $1,439,676 | 136,380 | Dec 13, 2024 |
| Dorsey Brian | Chief Operating Officer | Sale | 25,000 | $12.30 | $307,500 | 6,024 | Dec 11, 2024 |
| Chakma Justin | Chief Business Officer | Sale | 50,000 | $13.15 | $657,500 | 136,380 | Dec 10, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $13.16 | $658,000 | 1,148,499 | Dec 10, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $13.17 | $658,500 | 1,246,494 | Dec 10, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Option Exercise | 11,876 | $8.42 | $99,996 | 3,433,512 | Dec 6, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Option Exercise | 11,876 | $8.42 | $99,996 | 3,433,512 | Dec 6, 2024 |
| Chakma Justin | Chief Business Officer | Option Exercise | 45,000 | $0.84 | $37,800 | 181,380 | Dec 6, 2024 |
| Karas Eric | Chief Commercial Officer | Option Exercise | 3,717 | $1.50 | $5,576 | 9,410 | Dec 4, 2024 |
| Chakma Justin | Chief Business Officer | Sale | 45,000 | $13.67 | $615,150 | 136,380 | Dec 3, 2024 |
| Shawver Laura | — | Sale | 87,984 | $13.26 | $1,166,668 | 210,346 | Dec 3, 2024 |
| Chakma Justin | Chief Business Officer | Sale | 25,000 | $14.39 | $359,750 | 136,380 | Nov 25, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $13.95 | $697,500 | 1,198,499 | Nov 19, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $13.95 | $697,500 | 1,347,447 | Nov 19, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 4,955 | $17.64 | $87,406 | 1,296,494 | Nov 12, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 4,876 | $17.64 | $86,013 | 1,248,499 | Nov 12, 2024 |
| Deerfield Private Design Fund III, L.P. | — | Sale | 223,632 | $18.15 | $4,058,921 | 5,274,735 | Nov 11, 2024 |
| Scott Kathleen D. | Chief Financial Officer | Option Exercise | 12,500 | $1.50 | $18,750 | 17,449 | Oct 16, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 1,450 | $15.25 | $22,113 | 1,397,447 | Oct 15, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 48,550 | $14.86 | $721,453 | 1,398,897 | Oct 15, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $13.83 | $691,500 | 1,348,499 | Oct 8, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $13.83 | $691,500 | 1,348,499 | Oct 8, 2024 |
| Karas Eric | Chief Commercial Officer | Option Exercise | 10,000 | $1.50 | $15,000 | 15,693 | Sep 18, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $12.93 | $646,500 | 1,447,447 | Sep 17, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $12.93 | $646,500 | 1,398,499 | Sep 17, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFICER | Sale | 50,000 | $11.50 | $575,000 | 1,396,494 | Sep 10, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | Sale | 50,000 | $11.50 | $575,000 | 1,448,499 | Sep 10, 2024 |
| Thompson Peter A. | — | Sale | 83,695 | $13.00 | $1,088,035 | — | Aug 26, 2024 |
| ORBIMED CAPITAL LLC | — | Sale | 83,695 | $13.00 | $1,088,035 | — | Aug 26, 2024 |
| ORBIMED CAPITAL LLC | — | Sale | 13,300 | $14.61 | $194,313 | 544,677 | Aug 23, 2024 |
| Thompson Peter A. | — | Sale | 69,500 | $13.03 | $905,585 | 83,695 | Aug 22, 2024 |